uses pig islets to replace human islets that have been destroyed by type 1 diabetes.

We believe we can change peoples lives.

Our vision is to become the world leader in developing cellular therapies which can improve the lives of people living with serious disease. With DIABECELL  our lead product for type I diabetes in late stages of clinical development we are well on our way to achieving that goal.


At DOL we understand that the success of our business relies on both what we do and how we do it.  So, we pride ourselves on setting an exemplary standard of ethics, quality, safety and sustainability in everything we do.


Our values guide our day to day behaviours, how we work with each other and how we work with our partners.  They are:


Respect - Speak up - Strive